 |
 |

Risk of Unexplained Acute Liver Failure in Diabetes MellitusReply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In reply
Dr Graham claims that our study overestimated the rate of ALF and implies that the sponsor had undue influence over the study design. The essence of ALF is diminished hepatic function occurring over a period of a few months.1 Our criteria for probable ALF were new-onset encephalopathy, hyperbilirubinemia, and coagulopathy. At least one of these criteria of impaired liver function was required for a diagnosis of possible ALF. In our study,2 10 of 26 patients with probable or possible ALF without probable cause other than use of hypoglycemic agents had encephalopathy. If we count only these 10 patients, as Graham suggests, the ALF incidence estimate among patients using hypoglycemic agents would be approximately 4 per 100 000, still higher than the 1 per million rate he cites, and would not substantially alter our conclusion.
To support his claim that our estimates of ALF incidence are high, Graham cites 4 . . . [Full Text of this Article]
K. Arnold Chan, MD ScD
Boston Mass
Alison Truman, MS
Oakland Calif
Jerry H. Gurwitz, MD
Worcester Mass
Judith Hurley, RD MS
Albuquerque NM
Brian Martinson, PhD
Minneapolis Minn
Richard Platt, MD MS
Boston
Richard Moseley, MD
Ann Arbor Mich
Joe Selby, MD MPH
Oakland
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Risk of Unexplained Acute Liver Failure in Diabetes Mellitus
David J. Graham
Arch Intern Med. 2003;163(21):2649-2650.
EXTRACT
| FULL TEXT
A Cohort Study of the Incidence of Serious Acute Liver Injury in Diabetic Patients Treated With Hypoglycemic Agents
K. Arnold Chan, Alison Truman, Jerry H. Gurwitz, Judith S. Hurley, Brian Martinson, Richard Platt, James E. Everhart, Richard H. Moseley, Norah Terrault, Lynn Ackerson, and Joe V. Selby
Arch Intern Med. 2003;163(6):728-734.
ABSTRACT
| FULL TEXT
|